Related Experiment Video
Updated: Jan 24, 2026

Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes
Published on: February 8, 2018
A dual-modal GSH depletion and NIR-triggered nanoplatform for cascade-amplified phototherapy
Shuang Liu1, Xingyu Chen1, Xiaojin Liu2
1School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China.
Abstract:
In tumor phototherapy, the intracellular antioxidant defenses, such as high concentrations of glutathione (GSH) and inefficient generation of reactive oxygen species (ROS) significantly restrict the therapeutic efficacy. In this research, we construct a dual-modal GSH depletion and near-infrared (NIR)-triggered nanoplatform (Ce6@CDP) for cascade-amplified photothermal therapy (PTT) and photodynamic therapy (PDT). This nanoplatform featured a hollow mesoporous copper sulfide (CuS) core loaded with Ce6 and encapsulated by a disulfide bond-containing polymer (DS-ANPA-PEG). Upon tumor accumulation, the polymer DS-ANPA-PEG reacts with intracellular GSH to form highly reactive quinone methides (QMs), enabling rapid GSH depletion through alkylation. This dual GSH depletion intensifies oxidative stress, potentiating Ce6-based PDT efficacy. Additionally, the CuS carrier exhibits high photothermal conversion performance (η = 39.68 %), enabling PTT under 808 nm laser irradiation for synergistic tumor eradication. Both in vitro and in vivo studies demonstrate that the PDT/PTT combination therapy significantly inhibits tumor growth while maintaining negligible systemic toxicity. Our findings provide a rational design strategy for developing tumor-microenvironment-responsive multimodal nanoplatforms.
Insights
This study developed a novel nanoplatform that depletes glutathione (GSH) and uses near-infrared light to combine photodynamic therapy (PDT) and photothermal therapy (PTT) for enhanced tumor treatment with minimal toxicity.
Area of Science:
- Biomedical Engineering
- Materials Science
- Oncology
Background:
- Intracellular glutathione (GSH) and low reactive oxygen species (ROS) generation hinder phototherapy efficacy in tumors.
- Developing strategies to overcome tumor antioxidant defenses is crucial for effective cancer treatment.
Purpose of the Study:
- To construct a dual-modal nanoplatform for enhanced photothermal therapy (PTT) and photodynamic therapy (PDT).
- To create a nanoplatform that depletes GSH and is triggered by near-infrared (NIR) light for synergistic tumor eradication.
Main Methods:
- A nanoplatform (Ce6@CDP) was engineered with a copper sulfide (CuS) core and a disulfide bond-containing polymer (DS-ANPA-PEG) encapsulating Ce6.
- The polymer reacts with intracellular GSH, leading to GSH depletion and increased oxidative stress.
- CuS core facilitates NIR-triggered PTT, while Ce6 enables PDT, creating a combined therapeutic effect.
Main Results:
- The nanoplatform effectively depleted GSH and generated ROS, significantly enhancing PDT efficacy.
- High photothermal conversion efficiency of the CuS core enabled potent PTT under 808 nm laser irradiation.
- In vitro and in vivo studies confirmed significant tumor growth inhibition with negligible systemic toxicity.
Conclusions:
- The developed nanoplatform offers a promising strategy for synergistic PDT/PTT by overcoming tumor antioxidant defenses.
- This GSH-depleting, NIR-triggered system provides a rational design for responsive multimodal nanotherapeutics.
- The approach shows potential for effective and safe cancer treatment through combined therapeutic modalities.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
Intracellular Signaling Cascades
Rab Cascades
BJT Amplifiers
In BJT amplifier configurations, particularly in common-emitter setups, the transistor's role...
Operational Amplifiers
MOSFET Amplifiers

